These findings consistently suggest that TREM2 signalling is important for microglial phagocytosis, proliferation and recognition and clustering around plaques, but the exact mechanism through which TREM2 affects AD pathology may be disease stage-dependent [32,37,42–44,53,54]. The gene discussed is TREM2; the disease is Alzheimer disease.